Global Anti-Obesity Drugs Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
- Report Code : ARS2755110
- Published On: Jan, 2024
- Category : Healthcare & Pharma
- Pages : 114
-
This report aims to provide a comprehensive presentation of the global market for Anti-Obesity Drugs , with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Obesity Drugs .
The Anti-Obesity Drugs market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-Obesity Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Obesity Drugs manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
The global Anti-Obesity Drugs market size in 2022 is 1500.0 million US dollars, and it is expected to be 3100.0 million US dollars by 2029, with a compound annual growth rate of 10.60% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Anti-Obesity Drugs market include Pfizer, Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Novo Nordisk A/S, and Rhythm Pharmaceuticals, Inc.. The share of the top 3 players in the Anti-Obesity Drugs market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Anti-Obesity Drugs market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Centrally Acting accounted for XX% of Anti-Obesity Drugs market in 2022. Peripherally Acting share of XX%.
Hospital Pharmacies accounted for XX% of the Anti-Obesity Drugs market in 2022. Retail Pharmacies accounts for XX%.
Chapter Outline
Chapters 1-2: Introduces the product overview, market scope, product classification, application, and regional division.
Chapter 3: Analysis of the competitive environment of Anti-Obesity Drugs market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players' M&A and expansion in recent years.
Chapter 4: Provide global Anti-Obesity Drugs market value, volume and price data by region.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Anti-Obesity Drugs market country segmentation data.
Chapter 10: Analyzes the main companies in the Anti-Obesity Drugs industry, including their main businesses, products/services, sales, prices, revenue, gross margin, and the latest developments.
Chapter 11: Analyzes the Anti-Obesity Drugs manufacturing cost, including raw material analysis, manufacturing cost structure, and market dynamics.
Chapter 12: Analyzes the Anti-Obesity Drugs industry chain, including marketing channels, distributors and major downstream buyers.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria
Player list
Pfizer, Inc.
Boehringer Ingelheim International GmbH
GlaxoSmithKline PLC
Novo Nordisk A/S
Rhythm Pharmaceuticals, Inc.
Gelesis Holdings Inc. (PureTech Health)
Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
Vivus LLC
CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
KVK Tech, Inc.
Types list
Centrally Acting
Peripherally Acting
Application list
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
-
With tables and figures helping analyze worldwide Global Anti Obesity Drugs market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Anti-Obesity Drugs Market Overview1.1 Anti-Obesity Drugs Product Description
1.2 Anti-Obesity Drugs Market Segment by Type
1.3 Global Anti-Obesity Drugs Market Size by Type
1.3.1 Global Anti-Obesity Drugs Market Size Overview by Type
1.3.2 Global Anti-Obesity Drugs Historic Market Size Review by Type1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Obesity Drugs Sales Breakdown by Type
1.4.2 Europe Anti-Obesity Drugs Sales Breakdown by Type
1.4.3 Asia-Pacific Anti-Obesity Drugs Sales Breakdown by Type
1.4.4 Latin America Anti-Obesity Drugs Sales Breakdown by Type
1.4.5 Middle East and Africa Anti-Obesity Drugs Sales Breakdown by Type
2 Global Anti-Obesity Drugs by Application2.1 Anti-Obesity Drugs Market Segment by Application
2.2 Global Anti-Obesity Drugs Market Size by Application
2.2.1 Global Anti-Obesity Drugs Market Size Overview by Application
2.2.2 Global Anti-Obesity Drugs Historic Market Size Review by Application2.3 Key Regions Market Size Segment by Application
2.3.1 North America Anti-Obesity Drugs Sales Breakdown by Application
2.3.2 Europe Anti-Obesity Drugs Sales Breakdown by Application
2.3.3 Asia-Pacific Anti-Obesity Drugs Sales Breakdown by Application
2.3.4 Latin America Anti-Obesity Drugs Sales Breakdown by Application
2.3.5 Middle East and Africa Anti-Obesity Drugs Sales Breakdown by Application
3 Anti-Obesity Drugs Status and Outlook by Region3.1 Global Anti-Obesity Drugs Market Size and CAGR by Region: 2018 VS 2023 VS 2029
3.2 Global Anti-Obesity Drugs Historic Market Size by Region
3.2.1 Global Anti-Obesity Drugs Sales in Volume by Region
3.2.2 Global Anti-Obesity Drugs Sales in Value by Region
3.2.3 Global Anti-Obesity Drugs Sales Price and Gross Margin3.3 Global Anti-Obesity Drugs Forecasted Market Size by Region
3.3.1 Global Anti-Obesity Drugs Sales in Volume by Region
3.3.2 Global Anti-Obesity Drugs Sales in Value by Region
3.3.3 Global Anti-Obesity Drugs Sales Price and Gross Margin
4 Global Anti-Obesity Drugs Market Competition by Company4.1 Global Top Players by Anti-Obesity Drugs Sales
4.2 Global Top Players by Anti-Obesity Drugs Revenue
4.3 Global Top Players Anti-Obesity Drugs Price
4.4 Global Top Manufacturers Anti-Obesity Drugs Manufacturing Base Distribution, Sales Area, Product Type
4.5 Anti-Obesity Drugs Market Competitive Situation and Trends
4.5.1 Anti-Obesity Drugs Market Concentration Rate
4.5.2 Global 3 and 6 Largest Manufacturers by Anti-Obesity Drugs Sales and Revenue in 20224.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Obesity Drugs as of 2022)
4.7 Date of Key Manufacturers Enter into Anti-Obesity Drugs Market
4.8 Key Manufacturers Anti-Obesity Drugs Product Offered
4.9 Mergers & Acquisitions, Expansion
5 North America Anti-Obesity Drugs by Country5.1 North America Anti-Obesity Drugs Historic Market Size by Country
5.1.1 North America Anti-Obesity Drugs Sales in Volume by Country
5.1.2 North America Anti-Obesity Drugs Sales in Value by Country5.2 North America Anti-Obesity Drugs Forecasted Market Size by Country
5.2.1 North America Anti-Obesity Drugs Sales in Volume by Country
5.2.2 North America Anti-Obesity Drugs Sales in Value by Country
6 Europe Anti-Obesity Drugs by Country6.1 Europe Anti-Obesity Drugs Historic Market Size by Country
6.1.1 Europe Anti-Obesity Drugs Sales in Volume by Country
6.1.2 Europe Anti-Obesity Drugs Sales in Value by Country6.2 Europe Anti-Obesity Drugs Forecasted Market Size by Country
6.2.1 Europe Anti-Obesity Drugs Sales in Volume by Country
6.2.2 Europe Anti-Obesity Drugs Sales in Value by Country
7 Asia-Pacific Anti-Obesity Drugs by Country7.1 Asia-Pacific Anti-Obesity Drugs Historic Market Size by Country
7.1.1 Asia-Pacific Anti-Obesity Drugs Sales in Volume by Country
7.1.2 Asia-Pacific Anti-Obesity Drugs Sales in Value by Country7.2 Asia-Pacific Anti-Obesity Drugs Forecasted Market Size by Country
7.2.1 Asia-Pacific Anti-Obesity Drugs Sales in Volume by Country
7.2.2 Asia-Pacific Anti-Obesity Drugs Sales in Value by Country
8 Latin America Anti-Obesity Drugs by Country8.1 Latin America Anti-Obesity Drugs Historic Market Size by Country
8.1.1 Latin America Anti-Obesity Drugs Sales in Volume by Country
8.1.2 Latin America Anti-Obesity Drugs Sales in Value by Country8.2 Latin America Anti-Obesity Drugs Forecasted Market Size by Country
8.2.1 8.2.1 Latin America Anti-Obesity Drugs Sales in Volume by Country
8.2.2 8.2.2 Latin America Anti-Obesity Drugs Sales in Value by Country
9 Middle East and Africa Anti-Obesity Drugs by Country9.1 Middle East and Africa Anti-Obesity Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Obesity Drugs Sales in Volume by Country
9.1.2 Middle East and Africa Anti-Obesity Drugs Sales in Value by Country9.2 Middle East and Africa Anti-Obesity Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Obesity Drugs Sales in Volume by Country
9.2.2 Middle East and Africa Anti-Obesity Drugs Sales in Value by Country
10 Manufacturers Profiles10.1 Pfizer, Inc.
10.1.1 Pfizer, Inc. Information
10.1.2 Business Overview
10.1.3 Pfizer, Inc. Anti-Obesity Drugs Sales, Price, Revenue, Gross Margin
10.1.4 Anti-Obesity Drugs Products Offered
10.1.5 Pfizer, Inc. Recent Development10.2 Boehringer Ingelheim International GmbH
10.2.1 Boehringer Ingelheim International GmbH Information
10.2.2 Business Overview
10.2.3 Boehringer Ingelheim International GmbH Anti-Obesity Drugs Sales, Price, Revenue, Gross Margin
10.2.4 Anti-Obesity Drugs Products Offered
10.2.5 Boehringer Ingelheim International GmbH Recent Development10.3 GlaxoSmithKline PLC
10.3.1 GlaxoSmithKline PLC Information
10.3.2 Business Overview
10.3.3 GlaxoSmithKline PLC Anti-Obesity Drugs Sales, Price, Revenue, Gross Margin
10.3.4 Anti-Obesity Drugs Products Offered
10.3.5 GlaxoSmithKline PLC Recent Development10.4 Novo Nordisk A/S
10.4.1 Novo Nordisk A/S Information
10.4.2 Business Overview
10.4.3 Novo Nordisk A/S Anti-Obesity Drugs Sales, Price, Revenue, Gross Margin
10.4.4 Anti-Obesity Drugs Products Offered
10.4.5 Novo Nordisk A/S Recent Development10.5 Rhythm Pharmaceuticals, Inc.
10.5.1 Rhythm Pharmaceuticals, Inc. Information
10.5.2 Business Overview
10.5.3 Rhythm Pharmaceuticals, Inc. Anti-Obesity Drugs Sales, Price, Revenue, Gross Margin
10.5.4 Anti-Obesity Drugs Products Offered
10.5.5 Rhythm Pharmaceuticals, Inc. Recent Development10.6 Gelesis Holdings Inc. (PureTech Health)
10.6.1 Gelesis Holdings Inc. (PureTech Health) Information
10.6.2 Business Overview
10.6.3 Gelesis Holdings Inc. (PureTech Health) Anti-Obesity Drugs Sales, Price, Revenue, Gross Margin
10.6.4 Anti-Obesity Drugs Products Offered
10.6.5 Gelesis Holdings Inc. (PureTech Health) Recent Development
10.7 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
10.7.1 Currax Pharmaceuticals LLC (Currax Holdings USA LLC) Information
10.7.2 Business Overview
10.7.3 Currax Pharmaceuticals LLC (Currax Holdings USA LLC) Anti-Obesity Drugs Sales, Price, Revenue, Gross Margin
10.7.4 Anti-Obesity Drugs Products Offered
10.7.5 Currax Pharmaceuticals LLC (Currax Holdings USA LLC) Recent Development
10.8 Vivus LLC
10.8.1 Vivus LLC Information
10.8.2 Business Overview
10.8.3 Vivus LLC Anti-Obesity Drugs Sales, Price, Revenue, Gross Margin
10.8.4 Anti-Obesity Drugs Products Offered
10.8.5 Vivus LLC Recent Development
10.9 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
10.9.1 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH) Information
10.9.2 Business Overview
10.9.3 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH) Anti-Obesity Drugs Sales, Price, Revenue, Gross Margin
10.9.4 Anti-Obesity Drugs Products Offered
10.9.5 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH) Recent Development10.10 KVK Tech, Inc.
10.10.1 KVK Tech, Inc. Information
10.10.2 Business Overview
10.10.3 KVK Tech, Inc. Anti-Obesity Drugs Sales, Price, Revenue, Gross Margin
10.10.4 Anti-Obesity Drugs Products Offered
10.10.5 KVK Tech, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis11.1 Anti-Obesity Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses11.3 Anti-Obesity Drugs Industrial Chain Analysis
11.4 Anti-Obesity Drugs Market Dynamics
11.4.1 Anti-Obesity Drugs Industry Trends
11.4.2 Anti-Obesity Drugs Growth Drivers
11.4.3 Anti-Obesity Drugs Market Challenges
11.4.4 Anti-Obesity Drugs Market Restraints
12 Market Strategy Analysis, Distributors12.1 Sales Channel
12.2 Anti-Obesity Drugs Distributors
12.3 Anti-Obesity Drugs Downstream Customers
13 Research Findings and Conclusion
14 Methodology and Data Source14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation14.2 B Data Source
14.2.1 Legal Disclaimer
-
The Global Anti Obesity Drugs Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Global Anti Obesity Drugs Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
In recent years, the Global Anti Obesity Drugs Market has grown at an incredible rate. From 2024 to 2029, the market is expected to grow at a CAGR of yy%.
The influx of capital into the Global Anti Obesity Drugs Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
This latest research publication on the Global Anti Obesity Drugs Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.
